{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:47:21Z","timestamp":1792194441228,"version":"4.4.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s11060-026-05488-5","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:11:44Z","timestamp":1772269904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The 5-factor modified frailty index predicts local control and overall survival following spine stereotactic body radiation therapy"],"prefix":"10.1007","volume":"177","author":[{"given":"Samuel","family":"Adida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchet","family":"Taori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rabon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Bayley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal O.","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serah","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Flickinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Gerszten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta K.","family":"Sefcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"issue":"4","key":"5488_CR1","doi-asserted-by":"publisher","first-page":"300060522109166","DOI":"10.1177\/03000605221091665","volume":"50","author":"P Jaipanya","year":"2022","unstructured":"Jaipanya P, Chanplakorn P (Apr 2022) Spinal metastasis: narrative reviews of the current evidence and treatment modalities. J Int Med Res 50(4):3000605221091665. https:\/\/doi.org\/10.1177\/03000605221091665","journal-title":"J Int Med Res Apr"},{"issue":"2","key":"5488_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1470-2045(13)70556-4","volume":"15","author":"E Chow","year":"2014","unstructured":"Chow E, van der Linden YM, Roos D et al (Feb 2014) Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol 15(2):164\u2013171. https:\/\/doi.org\/10.1016\/S1470-2045(13)70556-4","journal-title":"Lancet Oncol Feb"},{"issue":"21","key":"5488_CR3","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1001\/jama.2019.17913","volume":"3","author":"PJ Hoskin","year":"2019","unstructured":"Hoskin PJ, Hopkins K, Misra V et al (Dec 2019) Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial. JAMA 3(21):2084\u20132094. https:\/\/doi.org\/10.1001\/jama.2019.17913","journal-title":"JAMA Dec"},{"issue":"6","key":"5488_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamaoncol.2023.0356","volume":"1","author":"S Ryu","year":"2023","unstructured":"Ryu S, Deshmukh S, Timmerman RD et al (Jun 2023) Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology\/RTOG 0631 Randomized Clinical Trial. JAMA Oncol 1(6):800\u2013807. https:\/\/doi.org\/10.1001\/jamaoncol.2023.0356","journal-title":"JAMA Oncol Jun"},{"issue":"7","key":"5488_CR5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","volume":"22","author":"A Sahgal","year":"2021","unstructured":"Sahgal A, Myrehaug SD, Siva S et al (Jul 2021) Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2\/3 trial. Lancet Oncol 22(7):1023\u20131033. https:\/\/doi.org\/10.1016\/S1470-2045(21)00196-0","journal-title":"Lancet Oncol Jul"},{"issue":"2","key":"5488_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ijrobp.2022.05.043","volume":"1","author":"KL Zeng","year":"2022","unstructured":"Zeng KL, Myrehaug S, Soliman H et al (Oct 2022) Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy. Int J Radiat Oncol Biol Phys 1(2):293\u2013300. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.05.043","journal-title":"Int J Radiat Oncol Biol Phys Oct"},{"key":"5488_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.radonc.2020.01.030","volume":"146","author":"R Singh","year":"2020","unstructured":"Singh R, Lehrer EJ, Dahshan B et al (May 2020) Single fraction radiosurgery, fractionated radiosurgery, and conventional radiotherapy for spinal oligometastasis (SAFFRON): A systematic review and meta-analysis. Radiother Oncol 146:76\u201389. https:\/\/doi.org\/10.1016\/j.radonc.2020.01.030","journal-title":"Radiother Oncol May"},{"issue":"1","key":"5488_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13014-023-02346-w","volume":"22","author":"E Kim","year":"2023","unstructured":"Kim E, Kim MS, Paik EK, Chang UK, Kong CB (Sep 2023) Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine. Radiat Oncol 22(1):156. https:\/\/doi.org\/10.1186\/s13014-023-02346-w","journal-title":"Radiat Oncol Sep"},{"issue":"5","key":"5488_CR9","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.3171\/2025.2.FOCUS24935","volume":"58","author":"S Adida","year":"2025","unstructured":"Adida S, Taori S, Sefcik RK, Burton SA, Flickinger JC, Gerszten PC (May 2025) Management for chordoma of the spine and sacrum with stereotactic radiosurgery. Neurosurg Focus 58(5):E17. https:\/\/doi.org\/10.3171\/2025.2.FOCUS24935","journal-title":"Neurosurg Focus MAY"},{"issue":"1","key":"5488_CR10","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2016.9.FOCUS16373","volume":"42","author":"DT Lockney","year":"2017","unstructured":"Lockney DT, Shub T, Hopkins B et al (Jan 2017) Spinal stereotactic body radiotherapy following intralesional curettage with separation surgery for initial or salvage chordoma treatment. Neurosurg Focus 42(1):E4. https:\/\/doi.org\/10.3171\/2016.9.FOCUS16373","journal-title":"Neurosurg Focus Jan"},{"key":"5488_CR11","doi-asserted-by":"publisher","first-page":"109969","DOI":"10.1016\/j.radonc.2023.109969","volume":"190","author":"RS Guninski","year":"2024","unstructured":"Guninski RS, Cuccia F, Alongi F et al (Jan 2024) Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline. Radiother Oncol 190:109969. https:\/\/doi.org\/10.1016\/j.radonc.2023.109969","journal-title":"Radiother Oncol Jan"},{"key":"5488_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2147\/CIA.S45300","volume":"9","author":"X Chen","year":"2014","unstructured":"Chen X, Mao G, Leng SX (2014) Frailty syndrome: an overview. Clin Interv Aging 9:433\u2013441. https:\/\/doi.org\/10.2147\/CIA.S45300","journal-title":"Clin Interv Aging"},{"issue":"1","key":"5488_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3171\/2023.2.SPINE221019","volume":"1","author":"CA Bowers","year":"2023","unstructured":"Bowers CA, Varela S, Conlon M et al (Jul 2023) Comparison of the Risk Analysis Index and the modified 5-factor frailty index in predicting 30-day morbidity and mortality after spine surgery. J Neurosurg Spine 1(1):136\u2013145. https:\/\/doi.org\/10.3171\/2023.2.SPINE221019","journal-title":"J Neurosurg Spine Jul"},{"issue":"3","key":"5488_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/neuros\/nyaa468","volume":"16","author":"N Agarwal","year":"2021","unstructured":"Agarwal N, Goldschmidt E, Taylor T et al (Feb 2021) Impact of Frailty on Outcomes Following Spine Surgery: A Prospective Cohort Analysis of 668 Patients. Neurosurgery 16(3):552\u2013557. https:\/\/doi.org\/10.1093\/neuros\/nyaa468","journal-title":"Neurosurgery Feb"},{"key":"5488_CR15","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1016\/j.wneu.2018.12.168","volume":"124","author":"DJ Weaver","year":"2019","unstructured":"Weaver DJ, Malik AT, Jain N, Yu E, Kim J, Khan SN (Apr 2019) The Modified 5-Item Frailty Index: A Concise and Useful Tool for Assessing the Impact of Frailty on Postoperative Morbidity Following Elective Posterior Lumbar Fusions. World Neurosurg 124:e626\u2013e632. https:\/\/doi.org\/10.1016\/j.wneu.2018.12.168","journal-title":"World Neurosurg Apr"},{"issue":"4","key":"5488_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3171\/2023.11.SPINE23951","volume":"1","author":"S Adida","year":"2024","unstructured":"Adida S, Tang A, Taori S et al (Apr 2024) Prediction of 30-day and 1-year postoperative complications after balloon-assisted kyphoplasty in the elderly using the Risk Analysis Index. J Neurosurg Spine 1(4):498\u2013504. https:\/\/doi.org\/10.3171\/2023.11.SPINE23951","journal-title":"J Neurosurg Spine Apr"},{"issue":"5","key":"5488_CR17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3171\/2021.8.SPINE21559","volume":"1","author":"AM Hersh","year":"2022","unstructured":"Hersh AM, Pennington Z, Hung B et al (May 2022) Comparison of frailty metrics and the Charlson Comorbidity Index for predicting adverse outcomes in patients undergoing surgery for spine metastases. J Neurosurg Spine 1(5):849\u2013857. https:\/\/doi.org\/10.3171\/2021.8.SPINE21559","journal-title":"J Neurosurg Spine May"},{"key":"5488_CR18","doi-asserted-by":"publisher","unstructured":"Subramaniam S, Aalberg JJ, Soriano RP, Divino CM (Feb 2018) New 5-factor modified frailty index using american college of surgeons NSQIP data. J Am Coll Surg 226(2):173\u2013181e8. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2017.11.005","DOI":"10.1016\/j.jamcollsurg.2017.11.005"},{"issue":"1","key":"5488_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3171\/2020.5.JNS20766","volume":"1","author":"AM Khalafallah","year":"2021","unstructured":"Khalafallah AM, Huq S, Jimenez AE, Brem H, Mukherjee D (Jul 2021) The 5-factor modified frailty index: an effective predictor of mortality in brain tumor patients. J Neurosurg 1(1):78\u201386. https:\/\/doi.org\/10.3171\/2020.5.JNS20766","journal-title":"J Neurosurg Jul"},{"issue":"1","key":"5488_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/neuros\/nyaa335","volume":"15","author":"S Huq","year":"2020","unstructured":"Huq S, Khalafallah AM, Jimenez AE et al (Dec 2020) Predicting Postoperative Outcomes in Brain Tumor Patients With a 5-Factor Modified Frailty Index. Neurosurgery 15(1):147\u2013154. https:\/\/doi.org\/10.1093\/neuros\/nyaa335","journal-title":"Neurosurgery Dec"},{"key":"5488_CR21","doi-asserted-by":"publisher","first-page":"124709","DOI":"10.1016\/j.wneu.2025.124709","volume":"205","author":"GD Xu","year":"2026","unstructured":"Xu GD, Kumar N, Yu A et al (Jan 2026) Prognostic performance of mFI-5 and mFI-11 Frailty Indices in Elective Spine Surgery: a systematic review and meta-analysis. World Neurosurg 205:124709. https:\/\/doi.org\/10.1016\/j.wneu.2025.124709","journal-title":"World Neurosurg Jan"},{"key":"5488_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000100177","volume":"20","author":"PC Gerszten","year":"2007","unstructured":"Gerszten PC, Burton SA, Ozhasoglu C (2007) CyberKnife radiosurgery for spinal neoplasms. Prog Neurol Surg 20:340\u2013358. https:\/\/doi.org\/10.1159\/000100177","journal-title":"Prog Neurol Surg"},{"issue":"3","key":"5488_CR23","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ijrobp.2018.02.035","volume":"1","author":"DC Ling","year":"2018","unstructured":"Ling DC, Flickinger JC, Burton SA et al (Jul 2018) Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity. Int J Radiat Oncol Biol Phys 1(3):602\u2013609. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.02.035","journal-title":"Int J Radiat Oncol Biol Phys Jul"},{"key":"5488_CR24","doi-asserted-by":"publisher","unstructured":"Adida S, Taori S, Bhatia S et al (Nov 2024) A case series and review of stereotactic body radiation therapy for contiguous multilevel spine metastases. J Neurooncol 11. https:\/\/doi.org\/10.1007\/s11060-024-04863-4","DOI":"10.1007\/s11060-024-04863-4"},{"key":"5488_CR25","doi-asserted-by":"publisher","unstructured":"Taori S, Adida S, Choi S et al (Oct 2025) Repeat stereotactic body radiation therapy for spinal metastases: long-term outcomes and toxicity. Neurosurg 7. https:\/\/doi.org\/10.1227\/neu.0000000000003772","DOI":"10.1227\/neu.0000000000003772"},{"issue":"4","key":"5488_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3171\/2023.7.JNS231214","volume":"1","author":"T Lucido","year":"2024","unstructured":"Lucido T, Rajkumar S, Rogowski B et al (Apr 2024) The 5-factor modified frailty index as a prognostic factor of stereotactic radiosurgery for metastatic disease to the brain. J Neurosurg 1(4):929\u2013937. https:\/\/doi.org\/10.3171\/2023.7.JNS231214","journal-title":"J Neurosurg Apr"},{"issue":"3","key":"5488_CR27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3171\/2010.3.SPINE09459","volume":"13","author":"MH Bilsky","year":"2010","unstructured":"Bilsky MH, Laufer I, Fourney DR et al (Sep 2010) Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine 13(3):324\u2013328. https:\/\/doi.org\/10.3171\/2010.3.SPINE09459","journal-title":"J Neurosurg Spine Sep"},{"key":"5488_CR28","doi-asserted-by":"publisher","unstructured":"Fisher CG, DiPaola CP, Ryken TC, the Spine Oncology Study Group (Oct 2010) A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from. Spine (Phila Pa (1976)) 15 2010;35(22):E1221-9) 35(22):E1221-9. https:\/\/doi.org\/10.1097\/BRS.0b013e3181e16ae2","DOI":"10.1097\/BRS.0b013e3181e16ae2"},{"issue":"16","key":"5488_CR29","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","volume":"16","author":"I Thibault","year":"2015","unstructured":"Thibault I, Chang EL, Sheehan J et al (Dec 2015) Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. Lancet Oncol 16(16):e595\u2013603. https:\/\/doi.org\/10.1016\/S1470-2045(15)00166-7","journal-title":"Lancet Oncol Dec"},{"issue":"6","key":"5488_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1227\/neu.0000000000001909","volume":"1","author":"A Abugharib","year":"2022","unstructured":"Abugharib A, Zeng KL, Tseng CL et al (Jun 2022) Spine Stereotactic Body Radiotherapy for Prostate Cancer Metastases and the Impact of Hormone Sensitivity Status on Local Control. Neurosurgery 1(6):743\u2013749. https:\/\/doi.org\/10.1227\/neu.0000000000001909","journal-title":"Neurosurgery Jun"},{"key":"5488_CR31","doi-asserted-by":"publisher","unstructured":"Adida S, Kann MR, Taori S et al (Sep 2024) Safety and efficacy of balloon-assisted kyphoplasty followed by stereotactic body radiation therapy for pathological fractures. Neurosurg 16. https:\/\/doi.org\/10.1227\/neu.0000000000003182","DOI":"10.1227\/neu.0000000000003182"},{"key":"5488_CR32","doi-asserted-by":"publisher","unstructured":"Adida S, Taori S, Donohue JK et al (Sep 2024) Stereotactic radiosurgery for patients with spinal metastases from prostate cancer. J Neurooncol 24. https:\/\/doi.org\/10.1007\/s11060-024-04821-0","DOI":"10.1007\/s11060-024-04821-0"},{"issue":"1","key":"5488_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11060-025-05126-6","volume":"175","author":"S Taori","year":"2025","unstructured":"Taori S, Adida S, Bayley JC et al (Oct 2025) Long term outcomes following upfront stereotactic body radiotherapy alone for spinal metastases. J Neurooncol 175(1):243\u2013254. https:\/\/doi.org\/10.1007\/s11060-025-05126-6","journal-title":"J Neurooncol Oct"},{"issue":"3","key":"5488_CR34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s11060-025-05033-w","volume":"173","author":"S Adida","year":"2025","unstructured":"Adida S, Taori S, Tirmizi Z et al (Jul 2025) Stereotactic body radiation therapy for spinal metastases from gastrointestinal primary cancers. J Neurooncol 173(3):683\u2013694. https:\/\/doi.org\/10.1007\/s11060-025-05033-w","journal-title":"J Neurooncol Jul"},{"issue":"5","key":"5488_CR35","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1227\/neu.0000000000003219","volume":"96","author":"S Taori","year":"2025","unstructured":"Taori S, Adida S, Kann MR et al (May 2025) Spine Stereotactic Radiosurgery Provides Long-Term Local Control and Overall Survival for Benign Intradural Tumors. Neurosurgery 96(5):1113\u20131123. https:\/\/doi.org\/10.1227\/neu.0000000000003219","journal-title":"NEUROSURGERY MAY"},{"key":"5488_CR36","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0","author":"U.S. Department of Health and Human Services","year":"2017","unstructured":"U.S. Department of Health and Human Services (2017) Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. U.S. Department of Health and Human Services, Bethesda, MD"},{"issue":"25","key":"5488_CR37","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1200\/JCO.2015.65.1497","volume":"1","author":"JJ Verlaan","year":"2016","unstructured":"Verlaan JJ, Choi D, Versteeg A et al (Sep 2016) Characteristics of Patients Who Survived\u2009<\u20093 Months or >\u20092 Years After Surgery for Spinal Metastases: Can We Avoid Inappropriate Patient Selection? J Clin Oncol 1(25):3054\u20133061. https:\/\/doi.org\/10.1200\/JCO.2015.65.1497","journal-title":"J Clin Oncol Sep"},{"issue":"5","key":"5488_CR38","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/neuros\/nyaa583","volume":"15","author":"KL Zeng","year":"2021","unstructured":"Zeng KL, Sahgal A, Tseng CL et al (Apr 2021) Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events. Neurosurgery 15(5):971\u2013979. https:\/\/doi.org\/10.1093\/neuros\/nyaa583","journal-title":"Neurosurgery Apr"},{"issue":"2","key":"5488_CR39","doi-asserted-by":"publisher","first-page":"e2355409","DOI":"10.1001\/jamanetworkopen.2023.55409","volume":"5","author":"BJJ Bindels","year":"2024","unstructured":"Bindels BJJ, Mercier C, Gal R et al (Feb 2024) Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases: A Systematic Review and Meta-Analysis. JAMA Netw Open 5(2):e2355409. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.55409","journal-title":"JAMA Netw Open Feb"},{"key":"5488_CR40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3389\/fonc.2019.00337","volume":"9","author":"KL Zeng","year":"2019","unstructured":"Zeng KL, Tseng CL, Soliman H, Weiss Y, Sahgal A, Myrehaug S (2019) Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview. Front Oncol 9:337. https:\/\/doi.org\/10.3389\/fonc.2019.00337","journal-title":"Front Oncol"},{"issue":"5","key":"5488_CR41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3171\/2015.8.SPINE15844","volume":"24","author":"AJ Ghia","year":"2016","unstructured":"Ghia AJ, Chang EL, Bishop AJ et al (May 2016) Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I\/II trials. J Neurosurg Spine 24(5):829\u2013836. https:\/\/doi.org\/10.3171\/2015.8.SPINE15844","journal-title":"J Neurosurg Spine May"},{"issue":"3","key":"5488_CR42","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ijrobp.2025.05.078","volume":"1","author":"CB Jackson","year":"2025","unstructured":"Jackson CB, Boe LA, Zhang L et al (Nov 2025) Histologic Classifier of Radiosensitivity to Spine Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys 1(3):829\u2013838. https:\/\/doi.org\/10.1016\/j.ijrobp.2025.05.078","journal-title":"Int J Radiat Oncol Biol Phys Nov"},{"key":"5488_CR43","doi-asserted-by":"publisher","first-page":"109966","DOI":"10.1016\/j.radonc.2023.109966","volume":"190","author":"M Guckenberger","year":"2024","unstructured":"Guckenberger M, Andratschke N, Belka C et al (Jan 2024) ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastases. Radiother Oncol 190:109966. https:\/\/doi.org\/10.1016\/j.radonc.2023.109966","journal-title":"Radiother Oncol Jan"},{"issue":"1","key":"5488_CR44","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/2016.9.FOCUS16369","volume":"42","author":"Y Yamada","year":"2017","unstructured":"Yamada Y, Katsoulakis E, Laufer I et al (Jan 2017) The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery. Neurosurg Focus 42(1):E6. https:\/\/doi.org\/10.3171\/2016.9.FOCUS16369","journal-title":"Neurosurg Focus Jan"},{"issue":"2","key":"5488_CR45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.adro.2018.10.007","volume":"4","author":"KD Kelley","year":"2019","unstructured":"Kelley KD, Racareanu R, Sison CP et al (Apr-Jun 2019) Outcomes in the radiosurgical management of metastatic spine disease. Adv Radiat Oncol 4(2):283\u2013293. https:\/\/doi.org\/10.1016\/j.adro.2018.10.007","journal-title":"Adv Radiat Oncol Apr-Jun"},{"issue":"1","key":"5488_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijrobp.2019.09.038","volume":"1","author":"A Sahgal","year":"2021","unstructured":"Sahgal A, Chang JH, Ma L et al (May 2021) Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys 1(1):124\u2013136. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.09.038","journal-title":"Int J Radiat Oncol Biol Phys May"},{"issue":"1","key":"5488_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3171\/2012.4.SPINE11902","volume":"17","author":"DE Heron","year":"2012","unstructured":"Heron DE, Rajagopalan MS, Stone B et al (Jul 2012) Single-session and multisession CyberKnife radiosurgery for spine metastases-University of Pittsburgh and Georgetown University experience. J Neurosurg Spine 17(1):11\u201318. https:\/\/doi.org\/10.3171\/2012.4.SPINE11902","journal-title":"J Neurosurg Spine Jul"},{"issue":"2","key":"5488_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7785\/tcrt.2012.500239","volume":"11","author":"VB Patel","year":"2012","unstructured":"Patel VB, Wegner RE, Heron DE, Flickinger JC, Gerszten P, Burton SA (Apr 2012) Comparison of whole versus partial vertebral body stereotactic body radiation therapy for spinal metastases. Technol Cancer Res Treat 11(2):105\u2013115. https:\/\/doi.org\/10.7785\/tcrt.2012.500239","journal-title":"Technol Cancer Res Treat Apr"},{"issue":"6","key":"5488_CR49","doi-asserted-by":"publisher","first-page":"E1111","DOI":"10.1093\/neuros\/nyz349","volume":"1","author":"M Alghamdi","year":"2019","unstructured":"Alghamdi M, Sahgal A, Soliman H et al (Dec 2019) Postoperative Stereotactic Body Radiotherapy for Spinal Metastases and the Impact of Epidural Disease Grade. Neurosurgery 1(6):E1111\u2013E1118. https:\/\/doi.org\/10.1093\/neuros\/nyz349","journal-title":"Neurosurgery Dec"},{"issue":"10","key":"5488_CR50","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/neuonc\/not101","volume":"15","author":"A Al-Omair","year":"2013","unstructured":"Al-Omair A, Masucci L, Masson-Cote L et al (Oct 2013) Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy. Neuro Oncol 15(10):1413\u20131419. https:\/\/doi.org\/10.1093\/neuonc\/not101","journal-title":"Neuro Oncol Oct"},{"key":"5488_CR51","doi-asserted-by":"publisher","first-page":"110260","DOI":"10.1016\/j.radonc.2024.110260","volume":"195","author":"RO Kowalchuk","year":"2024","unstructured":"Kowalchuk RO, Mullikin TC, Spears GM et al (Jun 2024) Assessment of minimum target dose as a predictor of local failure after spine SBRT. Radiother Oncol 195:110260. https:\/\/doi.org\/10.1016\/j.radonc.2024.110260","journal-title":"Radiother Oncol Jun"},{"issue":"27","key":"5488_CR52","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","volume":"20","author":"A Sahgal","year":"2013","unstructured":"Sahgal A, Atenafu EG, Chao S et al (Sep 2013) Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J Clin Oncol 20(27):3426\u20133431. https:\/\/doi.org\/10.1200\/JCO.2013.50.1411","journal-title":"J Clin Oncol Sep"},{"key":"5488_CR53","doi-asserted-by":"publisher","unstructured":"Burgess L, Atenafu EG, Zeng KL et al (Jan 2026) Predictors of vertebral compression fracture following stereotactic body radiation therapy in SINS potentially unstable spinal metastases. Int J Radiat Oncol Biol Phys 27. https:\/\/doi.org\/10.1016\/j.ijrobp.2025.12.029","DOI":"10.1016\/j.ijrobp.2025.12.029"},{"issue":"3","key":"5488_CR54","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jamaoncol.2021.7008","volume":"1","author":"RO Kowalchuk","year":"2022","unstructured":"Kowalchuk RO, Johnson-Tesch BA, Marion JT et al (Mar 2022) Development and Assessment of a Predictive Score for Vertebral Compression Fracture After Stereotactic Body Radiation Therapy for Spinal Metastases. JAMA Oncol 1(3):412\u2013419. https:\/\/doi.org\/10.1001\/jamaoncol.2021.7008","journal-title":"JAMA Oncol Mar"},{"issue":"1","key":"5488_CR55","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2016.10.FOCUS16359","volume":"42","author":"MS Virk","year":"2017","unstructured":"Virk MS, Han JE, Reiner AS et al (Jan 2017) Frequency of symptomatic vertebral body compression fractures requiring intervention following single-fraction stereotactic radiosurgery for spinal metastases. Neurosurg Focus 42(1):E8. https:\/\/doi.org\/10.3171\/2016.10.FOCUS16359","journal-title":"Neurosurg Focus Jan"},{"issue":"12","key":"5488_CR56","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1016\/j.spinee.2014.03.043","volume":"1","author":"M Huisman","year":"2014","unstructured":"Huisman M, van der Velden JM, van Vulpen M et al (Dec 2014) Spinal instability as defined by the spinal instability neoplastic score is associated with radiotherapy failure in metastatic spinal disease. Spine J 1(12):2835\u20132840. https:\/\/doi.org\/10.1016\/j.spinee.2014.03.043","journal-title":"Spine J Dec"},{"issue":"2","key":"5488_CR57","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ijrobp.2015.06.006","volume":"1","author":"TC Lam","year":"2015","unstructured":"Lam TC, Uno H, Krishnan M et al (Oct 2015) Adverse Outcomes After Palliative Radiation Therapy for Uncomplicated Spine Metastases: Role of Spinal Instability and Single-Fraction Radiation Therapy. Int J Radiat Oncol Biol Phys 1(2):373\u2013381. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.06.006","journal-title":"Int J Radiat Oncol Biol Phys Oct"},{"issue":"1","key":"5488_CR58","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-020-03691-6","volume":"152","author":"KL Zeng","year":"2021","unstructured":"Zeng KL, Sahgal A, Husain ZA et al (Mar 2021) Local control and patterns of failure for Radioresistant spinal metastases following stereotactic body radiotherapy compared to a Radiosensitive reference. J Neurooncol 152(1):173\u2013182. https:\/\/doi.org\/10.1007\/s11060-020-03691-6","journal-title":"J Neurooncol Mar"},{"issue":"2","key":"5488_CR59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3171\/SPI-07\/08\/151","volume":"7","author":"EL Chang","year":"2007","unstructured":"Chang EL, Shiu AS, Mendel E et al (Aug 2007) Phase I\/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7(2):151\u2013160. https:\/\/doi.org\/10.3171\/SPI-07\/08\/151","journal-title":"J Neurosurg Spine Aug"},{"issue":"4","key":"5488_CR60","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3171\/2015.6.SPINE15294","volume":"24","author":"MW Chan","year":"2016","unstructured":"Chan MW, Thibault I, Atenafu EG et al (Apr 2016) Patterns of epidural progression following postoperative spine stereotactic body radiotherapy: implications for clinical target volume delineation. J Neurosurg Spine 24(4):652\u2013659. https:\/\/doi.org\/10.3171\/2015.6.SPINE15294","journal-title":"J Neurosurg Spine Apr"},{"issue":"2","key":"5488_CR61","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijrobp.2015.03.029","volume":"1","author":"I Thibault","year":"2015","unstructured":"Thibault I, Campbell M, Tseng CL et al (Oct 2015) Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases. Int J Radiat Oncol Biol Phys 1(2):353\u2013360. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.03.029","journal-title":"Int J Radiat Oncol Biol Phys Oct"},{"issue":"5","key":"5488_CR62","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.ijrobp.2016.03.022","volume":"1","author":"R Tao","year":"2016","unstructured":"Tao R, Bishop AJ, Brownlee Z et al (Aug 2016) Stereotactic Body Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase 1\u20132 Trials. Int J Radiat Oncol Biol Phys 1(5):1405\u20131413. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.03.022","journal-title":"Int J Radiat Oncol Biol Phys Aug"},{"issue":"5","key":"5488_CR63","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.ijrobp.2011.02.019","volume":"1","author":"ST Chao","year":"2012","unstructured":"Chao ST, Koyfman SA, Woody N et al (Apr 2012) Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases. Int J Radiat Oncol Biol Phys 1(5):1738\u20131743. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.02.019","journal-title":"Int J Radiat Oncol Biol Phys Apr"},{"issue":"1","key":"5488_CR64","first-page":"25","volume":"5","author":"G Jensen","year":"2017","unstructured":"Jensen G, Tang C, Hess KR et al (2017) Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgery. J Radiosurg SBRT 5(1):25\u201334","journal-title":"J Radiosurg SBRT"},{"key":"5488_CR65","doi-asserted-by":"publisher","unstructured":"Taori S, Adida S, Tang A et al (Feb 2024) The role of spine stereotactic radiosurgery for patients with breast cancer metastases. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-024-04599-1","DOI":"10.1007\/s11060-024-04599-1"},{"issue":"3","key":"5488_CR66","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s11060-025-05221-8","volume":"175","author":"MR Kann","year":"2025","unstructured":"Kann MR, Adida S, Taori S et al (Dec 2025) Stereotactic radiosurgery for lung cancer spinal metastases. Article. J Neuro-Oncol 175(3):1117\u20131130. https:\/\/doi.org\/10.1007\/s11060-025-05221-8","journal-title":"J Neuro-Oncol Dec"},{"issue":"6","key":"5488_CR67","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/cncr.34626","volume":"15","author":"RO Kowalchuk","year":"2023","unstructured":"Kowalchuk RO, Mullikin TC, Florez M et al (Mar 2023) Development and validation of a recursive partitioning analysis-based pretreatment decision-making tool identifying ideal candidates for spine stereotactic body radiation therapy. Cancer 15(6):956\u2013965. https:\/\/doi.org\/10.1002\/cncr.34626","journal-title":"Cancer Mar"},{"issue":"3","key":"5488_CR68","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3171\/SPI\/2008\/8\/3\/271","volume":"8","author":"A Ibrahim","year":"2008","unstructured":"Ibrahim A, Crockard A, Antonietti P et al (Mar 2008) Does spinal surgery improve the quality of life for those with extradural (spinal) osseous metastases? An international multicenter prospective observational study of 223 patients. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2007. J Neurosurg Spine 8(3):271\u2013278. https:\/\/doi.org\/10.3171\/SPI\/2008\/8\/3\/271","journal-title":"J Neurosurg Spine Mar"},{"key":"5488_CR69","doi-asserted-by":"publisher","unstructured":"Chou KN, Park DJ, Hori YS et al (Aug 2024) Stereotactic body radiotherapy for painful spinal metastases: a decade of experience at a single institution. J Neurosurg Spine 1\u20139. https:\/\/doi.org\/10.3171\/2024.5.SPINE231326","DOI":"10.3171\/2024.5.SPINE231326"},{"issue":"7","key":"5488_CR70","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1007\/s00330-023-09437-y","volume":"33","author":"Y Chen","year":"2023","unstructured":"Chen Y, Wang Q, Zhou G et al (Jul 2023) Predictive model based on DCE-MRI and clinical features for the evaluation of pain response after stereotactic body radiotherapy in patients with spinal metastases. Eur Radiol 33(7):4812\u20134821. https:\/\/doi.org\/10.1007\/s00330-023-09437-y","journal-title":"Eur Radiol Jul"},{"key":"5488_CR71","doi-asserted-by":"publisher","unstructured":"Chan AW, Zeng KL, Moore-Palhares D et al (Nov 2024) Spine stereotactic body radiation therapy in geriatric patients: implications of age and dose on Iatrogenic vertebral compression fracture risk. Int J Radiat Oncol Biol Phys 22. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.11.082","DOI":"10.1016\/j.ijrobp.2024.11.082"},{"key":"5488_CR72","doi-asserted-by":"publisher","unstructured":"Zakaria HM, Llaniguez JT, Telemi E et al (May 2020) Sarcopenia predicts overall survival in patients with lung, breast, prostate, or myeloma spine metastases undergoing stereotactic body radiation therapy (SBRT), independent of histology. Neurosurgery 1;86(5):705\u2013716. https:\/\/doi.org\/10.1093\/neuros\/nyz216","DOI":"10.1093\/neuros\/nyz216"},{"key":"5488_CR73","doi-asserted-by":"publisher","unstructured":"Adida S, Sefcik RK, Gerszten PC (Mar 2025) Comment on The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management. J Neurooncol 3. https:\/\/doi.org\/10.1007\/s11060-025-04983-5","DOI":"10.1007\/s11060-025-04983-5"},{"key":"5488_CR74","doi-asserted-by":"publisher","first-page":"110979","DOI":"10.1016\/j.jocn.2024.110979","volume":"13","author":"S Rajkumar","year":"2024","unstructured":"Rajkumar S, Kite T, Desai J et al (Dec 2024) The 5-factor modified frailty index as a prognostic factor following stereotactic radiosurgery for metastatic disease to the brain from non-small cell lung cancer: A multi-center cohort analysis. J Clin Neurosci 13:132:110979. https:\/\/doi.org\/10.1016\/j.jocn.2024.110979","journal-title":"J Clin Neurosci Dec"},{"issue":"3","key":"5488_CR75","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11060-024-04873-2","volume":"171","author":"S Herr","year":"2025","unstructured":"Herr S, Kite T, Vyas P et al (Feb 2025) The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management. J Neurooncol 171(3):581\u2013588. https:\/\/doi.org\/10.1007\/s11060-024-04873-2","journal-title":"J Neurooncol Feb"},{"key":"5488_CR76","doi-asserted-by":"publisher","first-page":"936904","DOI":"10.3389\/fimmu.2023.936904","volume":"14","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Wang Z, Song M et al (2023) Effects of systemic inflammation and frailty on survival in elderly cancer patients: Results from the INSCOC study. Front Immunol 14:936904. https:\/\/doi.org\/10.3389\/fimmu.2023.936904","journal-title":"Front Immunol"},{"issue":"1","key":"5488_CR77","doi-asserted-by":"publisher","first-page":"102205","DOI":"10.1016\/j.esmoop.2023.102205","volume":"9","author":"A Di Meglio","year":"2024","unstructured":"Di Meglio A, Vaz-Luis I (Jan 2024) Systemic inflammation and cancer-related frailty: shifting the paradigm toward precision survivorship medicine. ESMO Open 9(1):102205. https:\/\/doi.org\/10.1016\/j.esmoop.2023.102205","journal-title":"ESMO Open Jan"},{"issue":"3","key":"5488_CR78","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/s0167-8140(02)00170-6","volume":"64","author":"E Chow","year":"2002","unstructured":"Chow E, Wu JS, Hoskin P, Coia LR, Bentzen SM, Blitzer PH (Sep 2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64(3):275\u2013280. https:\/\/doi.org\/10.1016\/s0167-8140(02)00170-6","journal-title":"Radiother Oncol Sep"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05488-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05488-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05488-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:38:01Z","timestamp":1776069481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05488-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["5488"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05488-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an observational study. The University of Pittsburgh Institutional Review Board has confirmed ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}